A pan-European registry-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis (Dream to TREAT AD)

12/01/2024
10/03/2025
EU PAS number:
EUPAS108468
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s)

Data source(s), other

TREAT NL/BE, A-STAR Ireland, A-STAR UK, SCRATCH Denmark

Data sources (types)

Disease registry
Use of a Common Data Model (CDM)

CDM mapping

Yes

CDM Mappings

CDM name (other)

Study-specific harmonised dataset
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No